Literature DB >> 8922569

Prospective evaluation of fever of unknown origin in patients infected with the human immunodeficiency virus. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas.

F Lozano1, J Torre-Cisneros, A Bascuñana, J Polo, P Viciana, M A García-Ordóñez, J Hernández-Quero, M Márquez, A Vergara, F Díez, E Pujol, M Torres-Tortosa, J Pasquau, J J Hernández-Burruezo, I Suárez.   

Abstract

The aim of this study was to determine the frequency and aetiology of fever of unknown origin (FUO) in patients infected with the human immunodeficiency virus (HIV), to assess the value of the tests used in its diagnosis, and to evaluate possible models of diagnosis for the causes found most frequently. One hundred twenty-eight (3.5%) of 3603 hospitalised HIV-positive patients evaluated from October 1992 to December 1993 had FUO, defined by established criteria. Eighty-six percent of patients with FUO had previously progressed to AIDS. The median CD4+ cell count was 46/mm3. A definite diagnosis was made in 96 (75%) of the 128 patients and a possible diagnosis in 24 (18.7%). whilst no diagnosis was made in eight cases (6.2%). Tuberculosis (48.3%), visceral leishmaniasis (16%), and infection by Mycobacterium avium complex (6.9%) were the diseases found most frequently. The most useful diagnostic tests were liver biopsy (68.9%) and bone marrow aspirate/biopsy (39.7%). It is not possible to predict clinically the cases of FUO due to tuberculosis, whilst thrombocytopaenia < 100,000 cells/mm3 alone is useful for differentiating the cases of visceral leishmaniasis, with a negative predictive value of 95.2%.

Entities:  

Mesh:

Year:  1996        PMID: 8922569     DOI: 10.1007/bf01691956

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Fever of unexplained origin: report on 100 cases.

Authors:  R G PETERSDORF; P B BEESON
Journal:  Medicine (Baltimore)       Date:  1961-02       Impact factor: 1.889

2.  Tuberculosis in the AIDS era: a new threat from an old disease.

Authors:  P A Selwyn
Journal:  N Y State J Med       Date:  1991-06

Review 3.  Clinical utility of liver biopsy in patients with serum antibodies to the human immunodeficiency virus.

Authors:  M S Cappell; M S Schwartz; L Biempica
Journal:  Am J Med       Date:  1990-02       Impact factor: 4.965

4.  Visceral leishmaniasis (kala-azar) as an opportunistic infection in patients infected with the human immunodeficiency virus in Spain.

Authors:  C Montalban; R Martinez-Fernandez; J L Calleja; J D Garcia-Diaz; R Rubio; F Dronda; S Moreno; M Yebra; C Barros; J Cobo
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

5.  Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection.

Authors:  F Kramer; T Modilevsky; A R Waliany; J M Leedom; P F Barnes
Journal:  Am J Med       Date:  1990-10       Impact factor: 4.965

6.  Risk stratification for dissemination of tuberculosis in HIV-infected patients.

Authors:  J M Llibre; J Tor; J M Manterola; C Carbonell; J Roset
Journal:  Q J Med       Date:  1992-02

7.  Secular trends of tuberculosis in western Europe.

Authors:  M C Raviglione; P Sudre; H L Rieder; S Spinaci; A Kochi
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

8.  Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection.

Authors:  R W Shafer; D S Kim; J P Weiss; J M Quale
Journal:  Medicine (Baltimore)       Date:  1991-11       Impact factor: 1.889

9.  Comparative yield of blood culture for fungi and mycobacteria, liver biopsy, and bone marrow biopsy in the diagnosis of fever of undetermined origin in human immunodeficiency virus-infected patients.

Authors:  V Prego; A E Glatt; V Roy; W Thelmo; H Dincsoy; J P Raufman
Journal:  Arch Intern Med       Date:  1990-02

10.  Actinomycetales infection in the acquired immunodeficiency syndrome.

Authors:  H A Holtz; D P Lavery; R Kapila
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

View more
  2 in total

1.  Diagnostic utility of bone marrow sampling in HIV positive patients.

Authors:  R P Brettle
Journal:  Genitourin Med       Date:  1997-04

2.  Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region.

Authors:  F Pasquau; J Ena; R Sanchez; J M Cuadrado; C Amador; J Flores; C Benito; C Redondo; J Lacruz; V Abril; J Onofre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.